Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • Peer reviewer login
    • WoS Reviewer Recognition Service
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • Peer reviewer login
    • WoS Reviewer Recognition Service
  • Alerts
  • Subscriptions

Cooperative effect of adenosine deaminase and ABO-secretor genetic complex on susceptibility to childhood asthma

N. Bottini, F. Ronchetti, F. Gloria-Bottini
European Respiratory Journal 2002 20: 1613-1615; DOI: 10.1183/09031936.02.00062302
N. Bottini
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
F. Ronchetti
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
F. Gloria-Bottini
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

To the Editor:

In a cohort of asthmatic children, we have recently shown that the ABO-secretor genetic complex influences susceptibility to asthma in children 1.

Since previous studies have shown an association of asthma with adenosine deaminase (ADA) genotype 2, we have searched for possible interactions between the two systems concerning their effects on susceptibility to asthma in children.

The sample study has been described in a previous paper 1 and was composed of 165 children, 109 males and 56 females, aged from 1 month–15 yrs. The criterion for inclusion in the study was the occurrence of two or more episodes of wheezing in the last 6 months, irrespective of aetiology/pathogenesis of the attack.

A consecutive series of 362 newborn infants from the same Caucasian population in Rome, Italy, was used as the control sample.

ADA phenotype was determined by starch gel electrophoresis according to the method of Spencer et al. 3. ABO and secretor phenotypes were determined according to a standard laboratory procedure 1.

Table 1⇓ shows the distribution of secretor-ABO-ADA joint genotype in asthmatic children and in the control population.

View this table:
  • View inline
  • View popup
Table 1—

Cooperative effect of adenosine deaminase (ADA) and secretor-ABO complex on susceptibility to asthma in children

The proportion of nonsecretor/O subjects with the ADA*1/*1 genotype was much higher in asthmatic children than in controls. On the contrary, the proportion of subjects with other phenotypes of secretor-ABO complex carrying the ADA*2 allele was much lower in asthmatic children than in controls. The other two phenotypic categories showed a similar proportion in asthmatic children and controls.

The lack of three-way interaction among secretor/ABO complex, ADA and disease (table 2⇓), suggests that ADA does not influence the effect of the secretor-ABO complex and vice versa, thus indicating that there was not an epistatic effect. On the contrary, the analysis suggests a cooperative effect of the genetic factors on susceptibility to asthma.

View this table:
  • View inline
  • View popup
Table 2—

Cooperative effect of adenosine deaminase (ADA) and secretor-ABO complex on susceptibility to asthma in children: three way contingency table analysis by a log linear model

The Chi-squared test of independence (table 3⇓) indicated that most of the difference between asthmatics and controls was due to the difference in the proportion of phenotypic categories nonsecretor/O with ADA*1/*1 phenotype (highest susceptibility to asthma) and other phenotypes of the secretor-ABO complex carrying the ADA*2 allele (lowest susceptibility to asthma). The odds ratio between these phenotypic categories was equal to 2.97.

View this table:
  • View inline
  • View popup
Table 3—

Cooperative effect of adenosine deaminase (ADA) and secretor-ABO complex on susceptibility to asthma in children: Chi-squared test (X2) of independence (asthmatics versus controls)

The secretor gene (FUT2) and the ABO system act in concert to build up oligosaccharide structures in exocrine secretions, including secretions in the respiratory tract. Specific oligosaccharide epitopes are necessary for recognition and adherence of microorganisms to the cell membrane, suggesting that genetic variation in these systems may influence susceptibility to viral and bacterial respiratory infections 4.

In purine metabolism, the classical function of the ADA enzyme is considered to be the regulation of intra- and extracellular levels of adenosine. Recently, it has been demonstrated that ADA is present on the surface of many cell types, including lymphocytes and neurons, where it can act as an ectoenzyme 5. A costimulatory role has been observed for ADA bound with CD26 on the lymphocyte surface, while ADA bound with adenosine 1 receptors (A1R) on the neuronal surface seems to act as a direct local modulator of adenosine action on A1R, and also as a cell adhesion molecule thus having a role in neural development and plasticity processes 5.

Since the ADA*2 allele is associated with lower ADA enzymatic activity, the negative association of the ADA*2 carrier genotype with the disease could indicate a role of decreased local and/or systemic adenosine levels in the pathogenesis of asthma. The suppressive effects of adenosine on lymphocyte function suggests that the ADA*2 allele could, in part, protect against higher immune reactivity.

Four adenosine receptors (A1, A2a, A2b and A3) have been discovered on the surface of many different cell types 6. In the respiratory system, the bronchoconstrictor effects of adenosine are well known 7. Thus, ADA polymorphism could modulate adenosine receptor activity in the respiratory tract with effects on the signal transduction pathway of adenosine and other mediators.

Based on the different roles of the ABO-secretor complex and ADA in the functional integrity of the respiratory tract, it is likely that the effects of the two systems on susceptibility to asthma follow different pathways: the ABO-secretor complex acting on the bacterial-viral infective component and ADA on the cellular reactivity component. Thus, a priori, an epistatic interaction was unlikely and our analysis has confirmed the expectation.

At present the genetic analysis of multifactorial disorders is a central problem in medical genetics and there is a general consensus on the necessity of a nonreductionist approach 8. The analysis of single genetic factors, based on a mendelian perspective, cannot solve the problem. It would be more productive to define a set of genes functionally related to the disease and to study simultaneously genetic and environmental factors involved in the susceptibility to the disease. A comprehensive approach will help to evaluate gene-to-gene and gene-to-environment interactions and will help in the understanding of pathogenic mechanisms.

    • © ERS Journals Ltd

    References

    1. ↵
      Ronchetti F, Villa MP, Ronchetti R, et al. ABO-secretor genetic complex and susceptibility to asthma in childhood. Eur Respir J 2001;17:1236–1238.
      OpenUrlAbstract/FREE Full Text
    2. ↵
      Ronchetti R, Lucarini N, Lucarelli P, et al. A genetic basis for heterogeneity of asthma syndrome in pediatric ages: adenosine deaminase phenotypes. J Allergy Clin Immunol 1984;74:81–84.
      OpenUrlCrossRefPubMedWeb of Science
    3. ↵
      Spencer H, Hopkinson D, Harris H. Adenosine deaminase polymorphism in man. Ann Hum Genet 1968;32:9–14.
      OpenUrlCrossRefWeb of Science
    4. ↵
      Kauffmann F, Frette C, Pham QT, Nafissi S, Bertrand JP, Oriol R. Association of blood group-related antigens to FEV1, wheezing and asthma. Am J Respir Crit Care Med 1996;153:76–82.
      OpenUrlPubMedWeb of Science
    5. ↵
      Franco R, Valuenzela A, Lluis C, Blanco J. Enzymatic and extraenzymatic role of ectoadenosine deaminase in lymphocytes. Immunol Rev 1998;161:27–42.
      OpenUrlCrossRefPubMedWeb of Science
    6. ↵
      Dalziel HH, Westfall DF. Receptors for adenine nucleotides and nucleosides: subclassification, distribution and molecular characterization. Pharmacol Rev 1994;46:449–466.
      OpenUrlPubMedWeb of Science
    7. ↵
      Polosa R, Holgate ST. Adenosine broncoprovocation: a promising marker of allergic inflammation in asthma?. Thorax 1997;52:919–923.
      OpenUrlCrossRefPubMedWeb of Science
    8. ↵
      Sing CF, Haviland MB, Reilly SL.. Genetic architecture of common multifactorial diseases. Ciba Foundation Symposium 197USA, John Wiley and Sons, 1996; pp. 211.
    View Abstract
    PreviousNext
    Back to top
    View this article with LENS
    Vol 20 Issue 6 Table of Contents
    • Table of Contents
    • Index by author
    Email

    Thank you for your interest in spreading the word on European Respiratory Society .

    NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

    Enter multiple addresses on separate lines or separate them with commas.
    Cooperative effect of adenosine deaminase and ABO-secretor genetic complex on susceptibility to childhood asthma
    (Your Name) has sent you a message from European Respiratory Society
    (Your Name) thought you would like to see the European Respiratory Society web site.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Print
    Citation Tools
    Cooperative effect of adenosine deaminase and ABO-secretor genetic complex on susceptibility to childhood asthma
    N. Bottini, F. Ronchetti, F. Gloria-Bottini
    European Respiratory Journal Dec 2002, 20 (6) 1613-1615; DOI: 10.1183/09031936.02.00062302

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero

    Share
    Cooperative effect of adenosine deaminase and ABO-secretor genetic complex on susceptibility to childhood asthma
    N. Bottini, F. Ronchetti, F. Gloria-Bottini
    European Respiratory Journal Dec 2002, 20 (6) 1613-1615; DOI: 10.1183/09031936.02.00062302
    del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
    Full Text (PDF)

    Jump To

    • Article
      • References
    • Figures & Data
    • Info & Metrics
    • PDF
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    More in this TOC Section

    • Treatable traits approach in interstitial lung disease
    • Reply: Treatable traits approach in interstitial lung disease
    • Reply: TB screening in migrants to the EU/EEA and UK
    Show more Correspondence

    Related Articles

    Navigate

    • Home
    • Current issue
    • Archive

    About the ERJ

    • Journal information
    • Editorial board
    • Press
    • Permissions and reprints
    • Advertising

    The European Respiratory Society

    • Society home
    • myERS
    • Privacy policy
    • Accessibility

    ERS publications

    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS books online
    • ERS Bookshop

    Help

    • Feedback

    For authors

    • Instructions for authors
    • Publication ethics and malpractice
    • Submit a manuscript

    For readers

    • Alerts
    • Subjects
    • Podcasts
    • RSS

    Subscriptions

    • Accessing the ERS publications

    Contact us

    European Respiratory Society
    442 Glossop Road
    Sheffield S10 2PX
    United Kingdom
    Tel: +44 114 2672860
    Email: journals@ersnet.org

    ISSN

    Print ISSN:  0903-1936
    Online ISSN: 1399-3003

    Copyright © 2023 by the European Respiratory Society